Larson Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
9,545
+2,288
| +32% | +$928K | 0.15% | 125 |
|
|
2025
Q1 | $3.61M | Buy |
7,257
+1,845
| +34% | +$918K | 0.17% | 112 |
|
|
2024
Q4 | $2.82M | Buy |
5,412
+523
| +11% | +$272K | 0.15% | 129 |
|
|
2024
Q3 | $3.02M | Buy |
4,889
+328
| +7% | +$203K | 0.17% | 110 |
|
|
2024
Q2 | $2.52M | Sell |
4,561
-498
| -10% | -$275K | 0.17% | 104 |
|
|
2024
Q1 | $2.94M | Buy |
5,059
+34
| +0.7% | +$19.8K | 0.23% | 84 |
|
|
2023
Q4 | $2.67M | Buy |
5,025
+875
| +21% | +$464K | 0.23% | 79 |
|
|
2023
Q3 | $2.1M | Sell |
4,150
-122
| -3% | -$61.7K | 0.21% | 93 |
|
|
2023
Q2 | $2.23M | Sell |
4,272
-126
| -3% | -$65.7K | 0.22% | 84 |
|
|
2023
Q1 | $2.53M | Buy |
4,398
+121
| +3% | +$69.7K | 0.28% | 70 |
|
|
2022
Q4 | $2.36M | Sell |
4,277
-274
| -6% | -$151K | 0.28% | 73 |
|
|
2022
Q3 | $2.31M | Buy |
4,551
+4,361
| +2,295% | +$2.21M | 0.33% | 51 |
|
|
2022
Q2 | $103K | Buy |
190
+128
| +206% | +$69.4K | 0.02% | 254 |
|
|
2022
Q1 | $37K | Sell |
62
-54
| -47% | -$32.2K | 0.01% | 427 |
|
|
2021
Q4 | $77K | Buy |
116
+71
| +158% | +$47.1K | 0.01% | 316 |
|
|
2021
Q3 | $26K | Hold |
45
| – | – | 0.01% | 419 |
|
|
2021
Q2 | $23K | Hold |
45
| – | – | 0.01% | 414 |
|
|
2021
Q1 | $21K | Sell |
45
-27
| -38% | -$12.6K | 0.01% | 408 |
|
|
2020
Q4 | $34K | Buy |
72
+20
| +38% | +$9.44K | 0.01% | 277 |
|
|
2020
Q3 | $23K | Sell |
52
-2
| -4% | -$885 | 0.01% | 296 |
|
|
2020
Q2 | $20K | Buy |
54
+1
| +2% | +$370 | 0.01% | 287 |
|
|
2020
Q1 | $15K | Buy |
53
+42
| +382% | +$11.9K | 0.01% | 248 |
|
|
2019
Q4 | $4K | Buy |
+11
| New | +$4K | ﹤0.01% | 399 |
|